human gfap (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
human gfap
Human Gfap, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gfap+duoset+elisa/Human+GFAP+DuoSet+ELISA/10__1016_slash_j__cej__2025__161118-297-7-9
Average 93 stars, based on 18 article reviews
Human Gfap, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gfap+duoset+elisa/Human+GFAP+DuoSet+ELISA/10__1016_slash_j__cej__2025__161118-297-7-9
Average 93 stars, based on 18 article reviews
human gfap - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study. Article Snippet: .. Serum GFAP of double negative atypical IDD patients was quantified using commercial Article Title: Altered metabolic function induced by amyloid-beta oligomers and PSEN1-mutations in iPSC-derived astrocytes Article Snippet: IL-6 and IL-8 levels in conditioned media were quantified using Quantikine immunoassays (HS600C and D8000C, R&D systems). .. GFAP was measured in CM using Article Title: Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders. Article Snippet: .. Concentrations of calcium-binding protein (S100B), MBP and GFAP were determined in the blood serum by enzyme-linked immunosorbent assay using the DY1820-05 Human S100B DuoSet ELISA, DY4228-05 Human MBP DuoSet ELISA and DY2594-05 Article Title: Neuroimaging, wearable sensors, and blood-based biomarkers reveal hyperacute changes in the brain after sub-concussive impacts. Article Snippet: .. Blood-based biomarkers of brain injury included serum neurofilament light (NfL) concentrations (pg/mL) a biomarker of axonal injury and plasma glialfibrillary acidic protein (GFAP), an astrocyte injury biomarker, and were analyzed by Quanterix Corp using the NF-Light Simoa Assay Advantage Kit (Quanterix Corp, MA, USA) and R&D Systems Article Title: Neuroimaging, wearable sensors, and blood-based biomarkers reveal hyperacute changes in the brain after sub-concussive impacts Article Snippet: .. Blood-based biomarkers of brain injury included serum neurofilament light (NfL) concentrations (pg/mL) a biomarker of axonal injury and plasma glial-fibrillary acidic protein (GFAP), an astrocyte injury biomarker, and were analyzed by Quanterix Corp using the NF-Light Simoa Assay Advantage Kit (Quanterix Corp, MA, USA) and R&D Systems Article Title: Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study Article Snippet: .. Serum GFAP of double negative atypical IDD patients was quantified using commercial Article Title: Postmortem biochemistry of GFAP, NSE and S100B in cerebrospinal fluid and in vitreous humor for estimation of postmortem interval: a pilot study. Article Snippet: Postmortem interval (PMI) estimation is a major challenge in forensic pathology [1, 2].. The forensic pathologist is often called upon to gather all the information during crime scene investigations, deferring the involvement of forensic sciences experts to later stages.. The “Site inspection form” proposed by the Parma Institute of Legal Medicine, recently shared with the European Council of Legal Medicine, represents an attempt to overcome these logistical problems [3]. Article Title: Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders Article Snippet: .. Concentrations of calcium-binding protein (S100B), MBP and GFAP were determined in the blood serum by enzyme-linked immunosorbent assay using the DY1820-05 Human S100B DuoSet ELISA, DY4228-05 Human MBP DuoSet ELISA and DY2594-05 Biomarker Discovery:Article Title: Neuroimaging, wearable sensors, and blood-based biomarkers reveal hyperacute changes in the brain after sub-concussive impacts. Article Snippet: .. Blood-based biomarkers of brain injury included serum neurofilament light (NfL) concentrations (pg/mL) a biomarker of axonal injury and plasma glialfibrillary acidic protein (GFAP), an astrocyte injury biomarker, and were analyzed by Quanterix Corp using the NF-Light Simoa Assay Advantage Kit (Quanterix Corp, MA, USA) and R&D Systems Article Title: Neuroimaging, wearable sensors, and blood-based biomarkers reveal hyperacute changes in the brain after sub-concussive impacts Article Snippet: .. Blood-based biomarkers of brain injury included serum neurofilament light (NfL) concentrations (pg/mL) a biomarker of axonal injury and plasma glial-fibrillary acidic protein (GFAP), an astrocyte injury biomarker, and were analyzed by Quanterix Corp using the NF-Light Simoa Assay Advantage Kit (Quanterix Corp, MA, USA) and R&D Systems Article Title: Postmortem biochemistry of GFAP, NSE and S100B in cerebrospinal fluid and in vitreous humor for estimation of postmortem interval: a pilot study. Article Snippet: Postmortem interval (PMI) estimation is a major challenge in forensic pathology [1, 2].. The forensic pathologist is often called upon to gather all the information during crime scene investigations, deferring the involvement of forensic sciences experts to later stages.. The “Site inspection form” proposed by the Parma Institute of Legal Medicine, recently shared with the European Council of Legal Medicine, represents an attempt to overcome these logistical problems [3]. Clinical Proteomics:Article Title: Neuroimaging, wearable sensors, and blood-based biomarkers reveal hyperacute changes in the brain after sub-concussive impacts. Article Snippet: .. Blood-based biomarkers of brain injury included serum neurofilament light (NfL) concentrations (pg/mL) a biomarker of axonal injury and plasma glialfibrillary acidic protein (GFAP), an astrocyte injury biomarker, and were analyzed by Quanterix Corp using the NF-Light Simoa Assay Advantage Kit (Quanterix Corp, MA, USA) and R&D Systems Article Title: Neuroimaging, wearable sensors, and blood-based biomarkers reveal hyperacute changes in the brain after sub-concussive impacts Article Snippet: .. Blood-based biomarkers of brain injury included serum neurofilament light (NfL) concentrations (pg/mL) a biomarker of axonal injury and plasma glial-fibrillary acidic protein (GFAP), an astrocyte injury biomarker, and were analyzed by Quanterix Corp using the NF-Light Simoa Assay Advantage Kit (Quanterix Corp, MA, USA) and R&D Systems |
